No Harm in Short Aspirin Duration After PCI for ACS

Less than a month of ticagrelor plus aspirin therapy followed by ticagrelor alone for 1 year after PCI for ACS was noninferior to dual antiplatelet therapy in the T-PASS trial.

Related Keywords

Lugano ,Ticino ,Switzerland ,Seoul ,Soult Ukpyolsi ,South Korea ,Marco Valgimigli ,Yonsei University College Of Medicine ,Cardiocentro Ticino Foundation ,Myeong Ki Hong ,Yonsei University College ,Transcatheter Cardiovascular Therapeutics ,Acute Coronary Syndrome Acs ,Cute Coronary Syndrome ,Cs ,Percutaneous Coronary Intervention ,Atherosclerotic Heart Disease ,Therosclerotic Cardiovascular Disease ,Oronary Heart Disease ,Schemic Heart Disease ,Antiplatelet Agent ,Clinical Research ,Clinical Trials ,Linical Studies ,Medical Literature ,Books ,Textbooks ,Ournals ,